Follow
Ziad Julier
Ziad Julier
Postdoctoral Researcher, Monash University
Verified email at monash.edu
Title
Cited by
Cited by
Year
Promoting tissue regeneration by modulating the immune system
Z Julier, AJ Park, PS Briquez, MM Martino
Acta biomaterialia 53, 13-28, 2017
6632017
Nanoparticle conjugation of CpG enhances adjuvancy for cellular immunity and memory recall at low dose
A De Titta, M Ballester, Z Julier, C Nembrini, L Jeanbart, AJ Van Der Vlies, ...
Proceedings of the National Academy of Sciences 110 (49), 19902-19907, 2013
2872013
Growth factor engineering strategies for regenerative medicine applications
X Ren, M Zhao, B Lash, MM Martino, Z Julier
Frontiers in bioengineering and biotechnology 7, 469, 2020
1932020
Macrophages provide a transient muscle stem cell niche via NAMPT secretion
D Ratnayake, PD Nguyen, FJ Rossello, VC Wimmer, JL Tan, LA Galvis, ...
Nature 591 (7849), 281-287, 2021
1202021
Growth factors with enhanced syndecan binding generate tonic signalling and promote tissue healing
M Mochizuki, E Güç, AJ Park, Z Julier, PS Briquez, GA Kuhn, R Müller, ...
Nature biomedical engineering 4 (4), 463-475, 2020
662020
The TLR4 agonist fibronectin extra domain A is cryptic, exposed by elastase-2; use in a fibrin matrix cancer vaccine
Z Julier, MM Martino, A De Titta, L Jeanbart, JA Hubbell
Scientific reports 5 (1), 8569, 2015
492015
Restoration of the healing microenvironment in diabetic wounds with matrix-binding IL-1 receptor antagonist
JL Tan, B Lash, R Karami, B Nayer, YZ Lu, C Piotto, Z Julier, MM Martino
Communications biology 4 (1), 422, 2021
352021
Immune regulation of tissue repair and regeneration via miRNAs—new therapeutic target
C Piotto, Z Julier, MM Martino
Frontiers in Bioengineering and Biotechnology 6, 401450, 2018
242018
Fibronectin EDA and CpG synergize to enhance antigen-specific Th1 and cytotoxic responses
Z Julier, A De Titta, AJ Grimm, E Simeoni, MA Swartz, JA Hubbell
Vaccine 34 (21), 2453-2459, 2016
212016
Enhancing the regenerative effectiveness of growth factors by local inhibition of interleukin-1 receptor signaling
Z Julier, R Karami, B Nayer, YZ Lu, AJ Park, K Maruyama, GA Kuhn, ...
Science advances 6 (24), eaba7602, 2020
172020
A superior extracellular matrix binding motif to enhance the regenerative activity and safety of therapeutic proteins
YK Alshoubaki, YZ Lu, JMD Legrand, R Karami, M Fossat, E Salimova, ...
NPJ Regenerative Medicine 8 (1), 25, 2023
12023
Il-1 receptor antagonist (il-1 ra) fusion proteins binding to the extracellular matrix
M Martino, Z Julier
US Patent App. 18/001,480, 2023
2023
Regulatory T-cell based therapy to promote repair and regeneration in multiple tissues
MM Martino, B Nayer, JL Tan, YK Alshoubakii, Z Julier, A Vasanthakumar, ...
TISSUE ENGINEERING PART A 29 (13-14), 2023
2023
A superior extracellular matrix binding motif to considerably enhance the regenerative activity and safety of therapeutic proteins
YK Alshoubaki, YZ Lu, J Legrand, R Karami, M Fossat, E Salimova, ...
TISSUE ENGINEERING PART A 29 (13-14), 2023
2023
Exploring the use of regulatory T cells to promote tissue repair and regeneration
B Nayer, J Tan, Y Alshoubaki, Z Julier, A Park, A Vasanthakumar, ...
TISSUE ENGINEERING PART A 28, 40-40, 2022
2022
Folding of complex redox proteins by dedicated molecular chaperones
C Grob, Z Julier, J Maillard
Swiss Society for Microbiology (SSM) Annual Meeting, 2016
2016
Engineering the Extra Domain A of fibronectin as a vaccine adjuvant and study of its role in tissue regeneration
Z Julier
EPFL, 2016
2016
Evaluation of the potential of the extra domain a of fibronectin as an adjuvant
Z Julier
2010
LBE
S Aubert, R Barmada, MD Bassan, K Becker Van Slooten, XL Bender, ...
What is regenerative medicine?
M Martino, J Legrand, J Tan, A Lu, Y Alshoubaki, B Nayer, M Mochizuki, ...
The system can't perform the operation now. Try again later.
Articles 1–20